Business Standard

Apollo Hospitals to rope in partner for photon therapy cancer centre

Equity infusion peged at Rs 350 crore; total capex of Rs 1,000 crore; entire business to be transferred to SPV

Apollo Hospitals
Premium

The Proton business was close to breakeven in the third quarter of financial year 2019-20, with almost 20 patients a month, which shows that it is a high-Ebitda business

Gireesh Babu Chennai
Apollo Hospitals is likely to finalise a partner for its proton-therapy centre, a first-of-its-kind advanced radiation therapy unit in this part of the world. The expected equity infusion is said to be about Rs 350 crore. The facility in Chennai is being developed with a capex of around Rs 1,000 crore and the entire business will be transferred to a separate vehicle, senior management of the company said.

The process had been delayed due to the lockdown in Chennai and the management would be able to get back to shareholders on the development by the end of June or first week

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in